Zurück zu Projekte

18288.1 PFLS-LS

Identification of novel strategies to treat obesity and type 2 diabetes

Zusammenfassung

Identification of novel strategies to treat obesity and type 2 diabetes

Weitere Texte

Abstract

Obesity and its associated co-morbidities such as type 2 diabetes, hypertension and cardiovascular complications have become a major burden worldwide with limited options for treatment. ETH Zürich and Glycemicon continue their successful collaboration on the application of THBA in type 2 diabetes therapy. In the current project both partners will develop a novel biocatalytic routes for production of THBA and elucidate whether THBA could also be employed a type 2 diabetes treatment in pets. Lastly the project aims to uncover new possibilities for the treatment of obesity through the identification of natural products which induce energy expenditure by activating brown fat.

Beteiligte

Nadia Mrosek

Wirtschaftspartner

nmrosek@glycemicon.com

Glycemicon AG Nadia Mrosek Schorenstrasse 16 8603 Schwerzenbach ZH CH

Christian Wolfrum

Kontaktperson

christian-wolfrum@ethz.ch

ETH Zürich Christian Wolfrum Schorenstrasse 16 8603 Schwerzenbach ZH CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2015-12-31
Enddatum
2017-12-31
Bewilligte Gesamtkosten
CHF 619968.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%